157 related articles for article (PubMed ID: 23382639)
1. Increased expression of tyrosine phosphatase SHP-2 in Helicobacter pylori-infected gastric cancer.
Jiang J; Jin MS; Kong F; Wang YP; Jia ZF; Cao DH; Ma HX; Suo J; Cao XY
World J Gastroenterol; 2013 Jan; 19(4):575-80. PubMed ID: 23382639
[TBL] [Abstract][Full Text] [Related]
2. DNA methyltransferase3a expression is an independent poor prognostic indicator in gastric cancer.
Cao XY; Ma HX; Shang YH; Jin MS; Kong F; Jia ZF; Cao DH; Wang YP; Suo J; Jiang J
World J Gastroenterol; 2014 Jul; 20(25):8201-8. PubMed ID: 25009393
[TBL] [Abstract][Full Text] [Related]
3. Elevated serum matrix metalloproteinase-3 and -7 in H. pylori-related gastric cancer can be biomarkers correlating with a poor survival.
Yeh YC; Sheu BS; Cheng HC; Wang YL; Yang HB; Wu JJ
Dig Dis Sci; 2010 Jun; 55(6):1649-57. PubMed ID: 19690958
[TBL] [Abstract][Full Text] [Related]
4. The CagA protein of Helicobacter pylori is translocated into epithelial cells and binds to SHP-2 in human gastric mucosa.
Yamazaki S; Yamakawa A; Ito Y; Ohtani M; Higashi H; Hatakeyama M; Azuma T
J Infect Dis; 2003 Jan; 187(2):334-7. PubMed ID: 12552462
[TBL] [Abstract][Full Text] [Related]
5. Associations of a PTPN11 G/A polymorphism at intron 3 with Helicobactor pylori seropositivity, gastric atrophy and gastric cancer in Japanese.
Hishida A; Matsuo K; Goto Y; Naito M; Wakai K; Tajima K; Hamajima N
BMC Gastroenterol; 2009 Jul; 9():51. PubMed ID: 19589142
[TBL] [Abstract][Full Text] [Related]
6. Gastric cancer patients with Helicobacter pylori infection have a poor prognosis.
Li G; Wang Z; Wang Z; Xu J; Cui J; Cai S; Zhan W; He Y
J Surg Oncol; 2013 Dec; 108(7):421-6. PubMed ID: 24037736
[TBL] [Abstract][Full Text] [Related]
7. Association of polymorphism of PTPN 11 encoding SHP-2 with gastric atrophy but not gastric cancer in Helicobacter pylori seropositive Chinese population.
Jiang J; Jia ZF; Kong F; Jin MS; Wang YP; Tian S; Suo J; Cao X
BMC Gastroenterol; 2012 Jul; 12():89. PubMed ID: 22788847
[TBL] [Abstract][Full Text] [Related]
8. Increased plasmacytic differentiation in gastric mucosa-associated lymphoid tissue lymphomas: Helicobacter pylori eradication response and IgG4+ plasma cell association.
Park S; Ahn S; Hong M; Ko YH
Hum Pathol; 2017 Jan; 59():113-119. PubMed ID: 27697589
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of Helicobacter pylori infection in advanced gastric carcinoma.
Araújo-Filho I; Brandão-Neto J; Pinheiro LA; Azevedo IM; Freire FH; Medeiros AC
Arq Gastroenterol; 2006; 43(4):288-92. PubMed ID: 17406757
[TBL] [Abstract][Full Text] [Related]
10.
Liu LP; Sheng XP; Shuai TK; Zhao YX; Li B; Li YM
World J Gastroenterol; 2018 Oct; 24(40):4565-4577. PubMed ID: 30386106
[TBL] [Abstract][Full Text] [Related]
11. Correlations among Helicobacter pylori infection and the expression of cyclooxygenase-2 and vascular endothelial growth factor in gastric mucosa with intestinal metaplasia or dysplasia.
Liu D; He Q; Liu C
J Gastroenterol Hepatol; 2010 Apr; 25(4):795-9. PubMed ID: 20492336
[TBL] [Abstract][Full Text] [Related]
12. MET4 expression predicts poor prognosis of gastric cancers with Helicobacter pylori infection.
Sakamoto N; Tsujimoto H; Takahata R; Cao B; Zhao P; Ito N; Shimazaki H; Ichikura T; Hase K; Vande Woude GF; Shinomiya N
Cancer Sci; 2017 Mar; 108(3):322-330. PubMed ID: 28012218
[TBL] [Abstract][Full Text] [Related]
13. Role of gastrin in gastric cancerogenesis in Helicobacter pylori infected humans.
Konturek PC; Konturek SJ; Bielanski W; Karczewska E; Pierzchalski P; Duda A; Starzynska T; Marlicz K; Popiela T; Hartwich A; Hahn EG
J Physiol Pharmacol; 1999 Dec; 50(5):857-73. PubMed ID: 10695565
[TBL] [Abstract][Full Text] [Related]
14. Abnormal DNA-PKcs and Ku 70/80 expression may promote malignant pathological processes in gastric carcinoma.
Li W; Xie C; Yang Z; Chen J; Lu NH
World J Gastroenterol; 2013 Oct; 19(40):6894-901. PubMed ID: 24187467
[TBL] [Abstract][Full Text] [Related]
15. Association of Helicobacter pylori cagA Gene with Gastric Cancer and Peptic Ulcer in Saudi Patients.
Saber T; Ghonaim MM; Yousef AR; Khalifa A; Al Qurashi H; Shaqhan M; Samaha M
J Microbiol Biotechnol; 2015 Jul; 25(7):1146-53. PubMed ID: 25791852
[TBL] [Abstract][Full Text] [Related]
16. Association between serum pepsinogens and polymorphismof PTPN11 encoding SHP-2 among Helicobacter pylori seropositive Japanese.
Goto Y; Ando T; Yamamoto K; Tamakoshi A; El-Omar E; Goto H; Hamajima N
Int J Cancer; 2006 Jan; 118(1):203-8. PubMed ID: 16032704
[TBL] [Abstract][Full Text] [Related]
17. Biopsy site for detecting Helicobacter pylori infection in patients with gastric cancer.
Kim CG; Choi IJ; Lee JY; Cho SJ; Nam BH; Kook MC; Hong EK; Kim YW
J Gastroenterol Hepatol; 2009 Mar; 24(3):469-74. PubMed ID: 19067779
[TBL] [Abstract][Full Text] [Related]
18. Does the method of Helicobacter pylori detection influence the association with gastric cancer risk?
Enroth H; Kraaz W; Rohan T; Nyrén O; Engstrand L
Scand J Gastroenterol; 2002 Aug; 37(8):884-90. PubMed ID: 12229961
[TBL] [Abstract][Full Text] [Related]
19. Serum pepsinogen 1 and anti-Helicobacter pylori IgG antibodies as predictors of gastric cancer risk in Finnish males.
Song M; Camargo MC; Weinstein SJ; Murphy G; Freedman ND; Koshiol J; Stolzenberg-Solomon RZ; Abnet CC; Männistö S; Albanes D; Rabkin CS
Aliment Pharmacol Ther; 2018 Feb; 47(4):494-503. PubMed ID: 29243850
[TBL] [Abstract][Full Text] [Related]
20. Analysis of the correlation between P27 expression and Helicobacter pylori infection in gastric cancer.
Li L; Wu W; Zheng W; Hui Q; Zhao C
APMIS; 2022 Jan; 130(1):21-25. PubMed ID: 34741767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
